Department of Nutrition and Metabolism, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto, Tokushima 770-8503, Japan.
Department of Nutrition Management, Cancer Institute Hospital of JFCR, 3-8-31 Ariake, Koto-ku, Tokyo 135-0063, Japan.
Nutrients. 2024 Mar 15;16(6):851. doi: 10.3390/nu16060851.
Patients undergoing gastrectomy for gastric cancer may experience alterations in olfaction, yet the association between olfactory changes and postoperative weight loss remains uncertain. This study aimed to elucidate the relationship between olfactory changes and postoperative weight loss in patients with gastric cancer. Patients who underwent radical gastrectomy for gastric cancer between February 2022 and August 2022 were included in the study. Those experiencing a higher Visual Analog Scale (VAS) score postoperatively compared to preoperatively were deemed to have undergone olfactory changes. Postoperative weight loss was determined using the 75th percentile as a cutoff value, designating patients surpassing this threshold as experiencing significant weight loss. Multivariate logistic regression analysis was employed to identify risk factors for postoperative weight loss, with statistical significance set at < 0.05. Out of 58 patients, 10 (17.2%) exhibited olfactory changes. The rate of postoperative weight loss at one month was markedly higher in the group with olfactory changes compared to those without (9.6% versus 6.2%, respectively; = 0.002). In addition, the group experiencing olfactory changes demonstrated significantly lower energy intake compared to the group without such changes (1050 kcal versus 1250 kcal, respectively; = 0.029). Logistic regression analysis revealed olfactory changes as an independent risk factor for significant weight loss at one month postoperatively (odds ratio: 7.64, 95% confidence interval: 1.09-71.85, = 0.048). In conclusion, olfactory changes emerged as an independent risk factor for postoperative weight loss at one month in patients with gastric cancer following gastrectomy.
接受胃癌胃切除术的患者可能会出现嗅觉改变,但嗅觉变化与术后体重减轻之间的关系尚不确定。本研究旨在阐明胃癌患者嗅觉变化与术后体重减轻之间的关系。
纳入 2022 年 2 月至 2022 年 8 月期间接受根治性胃切除术治疗胃癌的患者。与术前相比,术后视觉模拟量表(VAS)评分较高的患者被认为嗅觉发生改变。术后体重减轻采用第 75 百分位作为截断值,超过此阈值的患者被认为体重显著减轻。采用多变量逻辑回归分析确定术后体重减轻的危险因素,统计显著性设为 < 0.05。
在 58 例患者中,有 10 例(17.2%)出现嗅觉改变。与无嗅觉改变的患者相比,有嗅觉改变的患者术后 1 个月体重减轻的发生率明显更高(9.6%对 6.2%; = 0.002)。此外,有嗅觉改变的患者与无嗅觉改变的患者相比,术后能量摄入明显减少(分别为 1050 千卡和 1250 千卡; = 0.029)。逻辑回归分析显示,嗅觉改变是术后 1 个月体重显著减轻的独立危险因素(优势比:7.64,95%置信区间:1.09-71.85, = 0.048)。
总之,嗅觉改变是胃癌胃切除术后 1 个月体重减轻的独立危险因素。